Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

[18F]-3-Fluoro-4-amynopyridine, a novel radiotracer surrogate of myelin content in nonhuman primates

Maxime Donadieu, Omar Al-Louzi, Pedro Brugarolas, Zeping Wang, Hannah Kelly, Swati Shah, Frank Ye, Xiang Zhang, Rolf Swenson, Brian Popko, Steven Jacobson, Dima Hammoud, Pascal Sati and Daniel Reich
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 151;
Maxime Donadieu
1NINDS, TNS NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar Al-Louzi
1NINDS, TNS NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Brugarolas
2Massachusetts General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeping Wang
3Center for Infectious Disease Imaging, Radiology and Imaging Sciences NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Kelly
1NINDS, TNS NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swati Shah
3Center for Infectious Disease Imaging, Radiology and Imaging Sciences NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Ye
4NIMH, Neurophysiology Imaging Facility NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Zhang
5Imaging Probe Development Center, NHLB NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf Swenson
5Imaging Probe Development Center, NHLB NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Popko
6Department of Neurology The University of Chicago Chicago IL United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Jacobson
7NINDS, Viral Immunology Section NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dima Hammoud
3Center for Infectious Disease Imaging, Radiology and Imaging Sciences NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Sati
1NINDS, TNS NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Reich
1NINDS, TNS NIH Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

151

Introduction: Specific measurement of demyelination of the central nervous system (CNS) with in vivo imaging techniques is difficult. Magnetic resonance imaging (MRI) is the prevailing technique to study in vivo brain disorders; it has excellent spatial resolution and high sensitivity to myelin damage but lacks molecular specificity [1]. Positron emission tomography (PET) yields excellent biochemical specificity but suffers from relatively poor spatial resolution. Therefore, combining MRI and PET can be a powerful imaging strategy, benefiting from the complementary information provided by both techniques. We evaluated a new PET radiotracer ([18F]3-fluoro-4-amynopyridine, 3F4AP) targeting shaker-type potassium channels (Kv1.1 and Kv1.2), which are located in the juxtaparanodal region of myelinated axons and known to be exposed by demyelination [2-3].

Methods: Animals: 5 healthy marmosets (Callithrix jacchus; 3 males, 2 females) were imaged on a PET/CT scanner (Inveon, Siemens, Germany) and the following week on a 7-tesla MRI. Two of the animals were rescanned on both systems in order to measure experimental reproducibility. PET: [18F]3F4AP was synthesized as previously reported [2]. A one-hour dynamic scan was performed immediately after intravenous tail injection of 1 mCi of [18F]3F4AP. The images were then averaged (window 10-60 min) to increase the signal-to-noise ratio and facilitate co-registration with MRI (figure 1a). MRI: High-resolution proton density-weighted (PD-w) scans were acquired for each monkey using the following parameters (TE/TR: 16/2300 ms; in-plane resolution: 150 x 150 μm, slice thickness: 1 mm). A high-resolution T1-Magnetization-Prepared 2 Rapid Acquisition Gradient Echoes (MP2RAGE) was also acquired for each monkey using the following parameters (TE/TR: 3.5/6000 ms; in-plane resolution: 150 x 150 μm, thickness: 1 mm). T1-maps were computed by post-processing using MP2RAGE raw data. Post-processing: MRI and PET images were post-processed according to the pipeline in figure 1b. Standardized uptake value ratio (SUVR) was calculated for 54 cortical gray matter (GM) and 35 white matter (WM) regions of interest (ROI) [4] using the following formula: SUVR = SUV (ROI brain) / SUV (ROI liver). Signal in the liver was found to be consistent across animals and was used for normalization. Statistical analysis was then performed. Results: The scan-rescan data in the first monkey showed a mean difference of 5% for the average SUVR across the 54 GM ROI (range: 1%-11%) and 3% across the 35 WM ROIs (range: 0%-5%). The scan-rescan difference in the second monkey was 13% for average SUVR of GM ROI (9%-17%) and 13% for WM ROI (8%-16%) (figure 1c). Multivariable linear regression adjusting for voxel number per ROI, and bodyweight showed significant differences in SUVR values and T1 values between GM and WM ROIs for each monkey (p<0.05, figure 1d). Discussion/Conclusion: Similar to a previous study in other species [3], a higher uptake of 3F4AP in GM was observed as compared to WM in the brains of healthy nonhuman primates. The lower amount of myelin in GM and the higher number of potassium channels available for binding may explain the signal difference between the two types of cerebral tissues. A higher T1 value was also observed in GM as compared to WM, which is expected based on its known sensitivity to myelin content [5]. Overall, there was an excellent correspondence between the spatial distribution of 3F4AP and T1 map-derived intensity values, highlighting the potential of this combined approach for probing biological variations related to demyelination. There was also reasonable reproducibility of radiotracer uptake, which is promising for future quantification of 3F4AP uptake. In conclusion, our study illustrates the use of 3F4AP as a promising radiotracer surrogate of myelin integrity in the Callithrix jacchus, a relevant nonhuman primate model to study demyelinating diseases such as multiple sclerosis [6].

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[18F]-3-Fluoro-4-amynopyridine, a novel radiotracer surrogate of myelin content in nonhuman primates
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[18F]-3-Fluoro-4-amynopyridine, a novel radiotracer surrogate of myelin content in nonhuman primates
Maxime Donadieu, Omar Al-Louzi, Pedro Brugarolas, Zeping Wang, Hannah Kelly, Swati Shah, Frank Ye, Xiang Zhang, Rolf Swenson, Brian Popko, Steven Jacobson, Dima Hammoud, Pascal Sati, Daniel Reich
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 151;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[18F]-3-Fluoro-4-amynopyridine, a novel radiotracer surrogate of myelin content in nonhuman primates
Maxime Donadieu, Omar Al-Louzi, Pedro Brugarolas, Zeping Wang, Hannah Kelly, Swati Shah, Frank Ye, Xiang Zhang, Rolf Swenson, Brian Popko, Steven Jacobson, Dima Hammoud, Pascal Sati, Daniel Reich
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 151;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET CT Quantification to direct Alzheimer’s patients to anti-amyloid therapy
  • Multicenter trial study for usefulness of physical parameters toward the standardization of brain SPECT image: relation to visual analysis
  • Assessment of Brain Perfusion 123I-IMP SPECT imaging Using Low Energy High Resolution Collimator image reconstructed by Flash 3D
Show more Neurosciences

Basic Science - New tracers/analysis

  • [18F]FAZIN3: A novel PET imaging agent for Parkinson’s Disease
  • PET Imaging of nAChR Radioligands [18F]Nifene and [18F]ASEM to measure effects of Vagus Nerve Stimulation on the Acetylcholine System
  • Comparison of Methods for Striatal/Occipital FDOPA PET Uptake Ratio Formulation
Show more Basic Science - New tracers/analysis

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire